Meiji Announces Board Approval to Cancel Loan Facility to Subsidiary Alvogen Korea Holdings Ltd.

Release Date: June 27, 2026 Statement Date: June 26, 2026 Statement Time: 19:44:33 Company Code: 1795 Company Name: Meiji Subject: Announcement of Board Resolution to Cancel Loan Facility to Subsidiary Alvogen Korea Holdings Ltd. Applicable Clause: Item 51 Factual Date: June 26, 2026

Details: 1. Factual Date: June 26, 2026 2. Company Name: Meiji Chemical Pharmaceutical Co., Ltd. 3. Relationship with Company (Please enter 'Company' or 'Subsidiary'): Company 4. Cross-shareholding Ratio: 100% 5. Reason for Occurrence: In alignment with current operational realities, the company has decided to cancel the USD 15 million loan facility previously allocated to Alvogen Korea Holdings Ltd. 6. Response Measures: Not applicable 7. Other Matters to be Disclosed: This significant information simultaneously meets the criteria under Article 7, Paragraph 9, Item 9 of the Enforcement Rules of the Securities and Exchange Act, concerning matters that significantly affect shareholder rights or securities prices. No additional disclosures are required.